0001209191-15-042027.txt : 20150512
0001209191-15-042027.hdr.sgml : 20150512
20150512214720
ACCESSION NUMBER: 0001209191-15-042027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150508
FILED AS OF DATE: 20150512
DATE AS OF CHANGE: 20150512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valenzano Ken
CENTRAL INDEX KEY: 0001492123
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 15856306
MAIL ADDRESS:
STREET 1: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-08
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001492123
Valenzano Ken
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
0
1
0
0
SVP, Pharmacology & Biology
Common stock
2015-05-08
4
M
0
25000
A
25000
D
Common stock
2015-05-08
4
F
0
9313
10.80
D
15687
D
Common stock
2015-05-11
4
S
0
5000
10.8399
D
10687
D
Common stock
2015-05-11
4
S
0
8000
10.8513
D
2687
D
Restricted stock units
2015-05-08
4
M
0
25000
0.00
D
Common Stock
25000
25000
D
Restricted stock units convert into common stock on a one-for-one basis.
The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2014.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.7262 to $10.95. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.73 to $10.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.
/s/ Ken Valenzano
2015-05-12